Powered by

-Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR THIN LIQUID for oral suspension

Aug 06, 2019 - ENP Newswire

MONROE TOWNSHIP - Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announced the Food and Drug FDA approval for VARIBAR THIN LIQUID (barium sulfate) for oral suspension which is indicated for modified barium swallow (MBS) studies used to detect and assess the type and severity of swallowing disorders also known as dysphagia.

In the U.S., approximately 13 million (1 in 25) Americans suffer from dysphagi...